The Therapeutic Potential of the LncRNA lnc-HLX-2-7 in Group 3 Medulloblastomas in Children

Time: 4:00 pm
day: Day One


  • Delving into medulloblastoma (MB), an aggressive brain tumor that predominantly affects children
  • Identifying a novel oncogenic lncRNA, lnc-HLX-2-7, as a potential therapeutic target in group 3 MBs
  • Analyzing the importance of the lnc-HLX-2-7-HLX-MYC axis in regulating group 3 MB progression
  • Providing a strong rationale for using lnc-HLX-2-7 as a specific and potent therapeutic target for the group 3 MBs in children